| |
DIVISION SURGEONS
|
Office: 410-502-7710
Appointments: 410-955-6100
Fax: 410-502-7711
Email: mallaf@jhmi.edu |
Dr. Allaf
is an Assistant Professor of Urology and Biomedical Engineering at the Brady Urological Institute
and Director of Minimally Invasive and Robotic Surgery at the
Johns Hopkins Hospital. He joined the staff after
receiving his undergraduate and medical degrees from the Johns Hopkins
University and completing his residency and advanced training in
Urology at Johns Hopkins as well.
His main clinical interest includes the
treatment of kidney tumors and prostate cancer in the least morbid
way possible. He specializes in the management of kidney tumors
via laparoscopic (total and partial kidney removal) and percutaneous
(non-surgical) approaches. He also has an interest in the careful
and active observation of select small kidney tumors. His other
areas of focus include performing nerve sparing radical prostatectomy
in all its forms (open, laparoscopic, and robotic) as well as reconstructive
laparoscopy (pyeloplasty) and laparoscopic management of testicular
cancer (retroperitoneal lymph node dissection).
His research endeavors
involve investigating approaches to minimize the morbidity of urologic
surgery and the development of ways to decrease injury to the neurovascular
bundles and hasten erection recovery following radical prostatectomy.
Dr. Allaf has been the recipient of numerous academic awards, including
placing first in the 2005 American Urological Association clinical
and laboratory research annual essay contests. He has written and
published numerous research articles, textbook chapters, patents
and video presentations in the field of Laparoscopic and Robotic
Urologic Surgery. |
|
Office: 410-502-7710
Appointments: 410-955-6100
Fax: 410-502-7711
Email: david.chan@jhmi.edu |
David Y.S. Chan, M.D. is Assistant Professor of
Urology and Pathology at Johns Hopkins University School of Medicine
and a member of the Division of Endourology. His primary clinical
interest is in minimally invasive therapies for the treatment of
benign and malignant diseases of the urinary tract.
His particular clinical interests are prostate
cancer, bladder cancer, kidney cancer, benign prostate enlargement,
and kidney stones. His research is focused on urologic applications
of ablative energies, such as high intensity focused ultrasound
and radiofrequency ablation.
|
|
Office:
410-502-7454
Appointments:410-955-6100
Fax:410 502-7711
Email: gonzalgo@jhmi.edu |
Dr. Mark Gonzalgo is Assistant Professor of Urology and Oncology at The Brady Urological Institute. He joined the faculty after completing his general surgery and urology training at Johns Hopkins and a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center.
Dr. Gonzalgo is a board-certified and fellowship-trained urologic oncologist who treats patients with prostate, bladder, kidney, and testis cancers. He has expertise in robotic prostatectomy, robotic cystectomy for bladder cancer, nerve-sparing radical retropubic prostatectomy, orthotopic urinary diversion, and laparoscopic kidney surgery.
As a member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr. Gonzalgo works closely with medical oncologists, radiation oncologists, and research scientists to offer cancer patients the most advanced treatment available. This mutli-disciplinary approach to cancer treatment provides patients with highly individualized surgical and medical options ranging from open, laparoscopic, or robotic surgery to chemotherapy or radiation therapy.
Dr. Gonzalgo is a recognized expert in the field of DNA methylation and is particularly interested in developing new therapeutic approaches for cancer treatment. He has carried out pioneering research on the molecular biology and early detection of prostate, bladder, and kidney cancer and has published extensively on the scientific and clinical aspects of these diseases.
|
|
Office:
410-502-7454
Appointments:410-955-6100
Fax:410 502-7711
Email: Dr-Han@jhmi.edu |
Dr. Misop Han is an Assistant Professor of Urology at the Brady Urological Institute at The Johns Hopkins Hospital. He received his undergraduate, medical school and urology training at Johns Hopkins. After his training, he worked as an Assistant Professor of Urology at the Feinberg School of Medicine at Northwestern University and as a urologist at Northwestern Memorial Hospital in Chicago, Illinois. Dr. Han was head of Northwestern University's clinical database for prostate cancer research. In 2006, he was recruited back to join the faculty at the Brady Urological Institute at Johns Hopkins Hospital.
Dr. Han is a board-certified urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney cancers. He specializes in nerve-sparing radical retropubic prostatectomy, robotic-assisted laparoscopic radical prostatectomy and laparoscopic nephrectomy.
Dr. Han has received recognition for his research involving the outcome of surgery for prostate cancer and has received national awards for his research. His research interests include the outcome of radical prostatectomy and prediction modeling (what happens to men following surgery for prostate cancer). He has published extensively in these subjects(click here for details). He is actively involved in several clinical research projects with the database of more than 14,000 men who received surgery for prostate cancer at The Johns Hopkins Hospital.
|
|
Appointments: 410-955-6100
Fax:(410) 614-8487
Email: jjarow@jhmi.edu |
Jonathan P. Jarow, MD, Professor of Urology, Radiology, Pathology, and
Biochemistry, was born in Freeport, New York and graduated from Northwestern
University College and medical school. He completed his general surgical
and urological training at Johns Hopkins Hospital in 1986. He also completed
fellowship training in male reproductive medicine and erectile dysfunction
at Baylor College of Medicine and University of California San Francisco,
respectively. He was on faculty at Bowman Gray School of Medicine for ten
years and returned to Johns Hopkins in 1997.
Dr. Jarow has an active clinical practice specializing
in prostate and testis
cancer, male infertility, erectile
dysfunction and Peyronie's
disease. He has performed over 1,000 radical
prostatectomies and is an expert at robotic
assisted laparoscopic prostatectomy, performing more than
100 prostatectomies each year. He is the medical director of
the andrology laboratory for the department of pathology. |
He has teaching responsibilities
for both the School of Medicine and the School Public Health. His
research interests are in the outcomes of robotic prostatectomy
and the hormonal control of spermatogenesis. Dr. Jarow has two
NIH funded grants, one is a center grant (U54) to study male infertility
and the second is an RO1 to study hormonal control of spermatogenesis
with possible application to male contraception.
Dr. Jarow is a well-known author,
editor, and lecturer, having published more than 100 scientific
papers and chapters. He has served on the editorial boards of the
journals Urology, Journal of Urology, Journal of Andrology, and
World Journal of Urology. Dr. Jarow served as a consultant for
the examination committee of the American Board of Urology. Active
in numerous scientific organizations, Dr. Jarow was President of
several specialty societies including both the Society for the
Study of Male Reproduction and Society of Male Reproduction and
Urology of the American Society of Reproductive Medicine. He has
served as the chair for the American Urological Association Best
Practices Committee’s for both male infertility and erectile
dysfunction. |
|
Appointments:410-550-7008
Fax:410-550-3341
Email: bmatlag1@jhmi.edu |
Dr.
Brian Matlaga is Assistant Professor of Urology at The Brady Urological
Institute and the Director of Stone Disease at Johns Hopkins Bayview
Medical Center. Dr. Matlaga came to Johns Hopkins after completing
a fellowship in minimally invasive surgery and metabolic stone disease.
During his fellowship he was designated an American Foundation for
Urologic Disease Research Scholar, and was awarded the Outstanding
Research Scholar honor in recognition of his work involving the
treatment of patients with stone disease.
Dr. Matlaga’s main clinical
interest is the minimally invasive treatment of patients with metabolic
stone disease, including percutaneous nephrolithotomy, ureteroscopy,
and shock wave lithotripsy. In addition, Dr. Matlaga has an interest
in the holmium laser enucleation of the prostate (HoLEP), a minimally
invasive laser therapy for men with benign prostatic enlargement.
As the Director of Stone Disease,
Dr. Matlaga is actively engaged in clinical and basic science research
addressing the questions of: Which patients develop stones? How
do stones form? How well are we treating patients with stones? |
|
Appointments:
410 550-0013
Fax:(410)
550-3341
Email: cpavlov2@jhmi.edu |
Christian Pavlovich, M.D. is an Associate Professor of Urology and Director of
Urologic Oncology at the Johns Hopkins Bayview Medical Center. He came to Johns Hopkins after completing a Urologic Oncology fellowship at the National Cancer Institute, and is an NIH and Dept. of Defense-funded cancer researcher.
Dr. Pavlovich applies his surgical expertise in open, laparoscopic, and other
minimally invasive techniques primarily to patients with urologic cancers. His main
focus is the treatment of prostate, bladder, and kidney cancers with minimal
morbidity and maximal oncologic efficacy. To this effect, he has developed a busy
cancer practice, where he offers nerve-sparing laparoscopic,
robot-assisted laparoscopic, and open
radical prostatectomy for prostate cancer, laparoscopic and
robot-assisted radical cystectomy for bladder cancer, and open and laparoscopic
approaches to the kidney for kidney cancer.
|
|
Appointments: (410)
614-6662
Fax:(443) 287-1010
Email: rrodrig@jhmi.edu |
Dr. Rodriguez is an Associate Professor of Urology
at Johns Hopkins University School of Medicine, with secondary
appointments in Medical Oncology, Radiation Oncology, Viral Oncology,
Cellular &
Molecular Medicine. He is the urology residency program director
at Johns Hopkins, directing all the educational and administrative
aspects of resident education. His primary clinical interest is
in urological oncology including malignancies of the prostate,
kidney and bladder. He is also very active in cryosurgery of the
kidney, performing both percutaneous and laparoscopic cryoablation
of renal masses.
In addition, Dr. Rodriguez is a fully-trained,
NIH funded basic scientist with an active and highly productive research
laboratory. He is involved in the development and
evaluation of experimenta therapeutics for urological malignancies
including prostate and kidney cancer. He is a world expert in the
development and translation of adenoviral gene therapy vectors
for the treatment of prostate cancer. He also has active research
efforts into immunotherapies for prostate & kidney cancer and
the use of Histone Deacetyalase inhibitors for biochemical recurrence
of prostate cancer.
|
|
Appointments:410-502-3143
Email: eschaef4@jhmi.edu |
Edward M (Ted) Schaeffer, MD, PhD, Assistant Professor of Urology, Oncology and Pathology, was born in Palo Alto California and graduated from University of Chicago with undergraduate, graduate and medical degrees. He joined the faculty after completing his general surgery and urology training at Johns Hopkins.
Dr. Schaeffer has an active clinical practice in Urologic Oncology specializing in Prostate, Bladder and Kidney cancer. He has expertise in open, laparoscopic and robot treatment of these malignancies. As an active member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr Schaeffer participates in multidisciplinary approaches to the treatment of genitourinary cancers.
Dr Schaeffer is also a fully trained scientist and an expert in prostate development and prostate carcinogenesis. His laboratory currently investigates novel pathways of prostate and bladder carcinogenesis through utilization of experimental embryology and systems of epithelial injury repair.
|
PROCEDURES
For Kidney Stones:
Extracorporeal
shock wave lithotripsy (ESWL)
a non invasive technique that uses sound waves (also called shock
waves) to break a kidney stone into small pieces
Ureteroscopy:
is a procedure using a thin telescope
(ureteroscope), which is passed through the urethra (channel through
which urine flows out of the bladder) used to treat stones within
kidney or ureter. Percutaneous
Nephrolithotomy (PCNL): a minimally
invasive technique for removing large kidney stones through a small
incision made in the skin.
|
For Kidney Donation:
Laparoscopic
Live Donor Nephrectomy: is
a minimally invasive technique of kidney donation, which provides
the least amount of discomfort for the donor while maintaining the
health and quality of the kidney for transplantation.
|
For Kidney Blockage or Kidney Cysts:
Laparoscopic
Pyeloplasty: a minimally invasive
surgical technique used to reconstruct the drainage system of the
kidney in patients suffering from blockage of a kidney at the ureteropelvic
junction (i.e. the connection between the ureter or drainage tube
and the kidney).
Laparoscopic Renal Cyst Ablation
a minimally invasive surgical technique to
excise symptomatic kidney cyst.
|
For Adrenal Tumors:
Laparoscopic
Adrenalectomy a minimally invasive
surgical technique for removing a diseased
or cancerous adrenal gland.
|
|
Warning:
these video clips include footage from an actual surgery which
some viewers may find difficult to watch.
Nerve-Sparing
Robotic Radical Prostatectomy
Nerve-Sparing
Laparoscopic Radical Prostatectomy
Laparoscopic Nephrectomy
Laparoscopic Live Donor Nephrectomy
Laparoscopic Live Donor Nephrectomy
Percutaneous Nephrolithotomy (PCNL)
Ureteroscopy
Laparoscopic
Pelvic Organ Prolapse Repair (COLPOSUSPENSION)
Laparoscopic Pelvic Organ Prolapse Repair(COLPOSUSPENSION)
|
|
 |
